Skip to main content
SpringerLink
Log in

Testosterone Deficiency Syndrome

  • Chapter
  • First Online:
Clinical Uro-Andrology

  • 1028 Accesses

Abstract

Over the last two decades, the age-associated decline of serum testosterone levels in men has received attention. It has become clear that age as such plays a role in this decline, but conditions occurring in old age, such as obesity, diabetes mellitus, and cardiovascular disease, often clustered in metabolic syndrome, are quantitatively more significant. It has also become clear that the age-associated decline of serum testosterone has clinical significance and symptoms of hypogonadism are manifested.

The ailments of aging, such as osteoporosis, atherosclerosis, hypertension, cardiovascular disease, diabetes mellitus, lower urinary tract symptoms, and erectile dysfunction are traditionally regarded as distinct diagnostic/therapeutic entities, but there is a growing recognition that these entities are not disparate but interdependent in their etiology and that they require an integral diagnostic and therapeutic approach. Testosterone deficiency is a common denominator. Measurement of testosterone should be a pivotal component in the diagnostic workup of men suffering from the above conditions. And, if warranted by symptoms and laboratory findings, testosterone treatment should be given in addition to organ (system)-specific treatment. Traditionally, there has been a large degree of trepidation in administering testosterone to aging men for fear that testosterone treatment would worsen atherosclerosis resulting in cardiovascular disease, lower urinary tract symptoms, and malignant development of the prostate. These fears have not been substantiated in recent research. Professional scientific bodies have formulated guidelines for the responsible administration of testosterone to men with hypogonadism in whom lower-than-normal serum testosterone is found by laboratory tests.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Arafa M, Zohdy W, Aboulsoud S, Shamloul R (2012) Prevalence of late-onset hypogonadism in men with type 2 diabetes mellitus. Andrologia 44(Suppl 1):756–763

    PubMed  Google Scholar 

  • Aversa A, Isidori AM, Greco EA, Giannetta E, Gianfrilli D, Spera E, Fabbri A (2004) Hormonal supplementation and erectile dysfunction. Eur Urol 45(5):535–538

    CAS  PubMed  Google Scholar 

  • Aversa A, Bruzziches R, Francomano D, Rosano G, Isidori AM, Lenzi A, Spera G (2010a) Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study. J Sex Med 7(10):3495–3503

    CAS  PubMed  Google Scholar 

  • Aversa A, Bruzziches R, Francomano D, Spera G, Lenzi A (2010b) Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome. J Endocrinol Invest 33(11):776–783

    CAS  PubMed  Google Scholar 

  • Aversa A, Bruzziches R, Francomano D, Greco EA, Fornari R, Di Luigi L, Lenzi A, Migliaccio S (2012) Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study. Aging Male 15(2):96–102

    CAS  PubMed  Google Scholar 

  • Bagatell CJ, Heiman JR, Rivier JE, Bremner WJ (1994) Effects of endogenous testosterone and estradiol on sexual behavior in normal young men. J Clin Endocrinol Metab 78(3):711–716

    CAS  PubMed  Google Scholar 

  • Bancroft J (2005) The endocrinology of sexual arousal. J Endocrinol 186(3):411–427

    CAS  PubMed  Google Scholar 

  • Barrett-Connor E, Goodman-Gruen D, Patay B (1999a) Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 84(10):3681–3685

    CAS  PubMed  Google Scholar 

  • Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D (1999b) Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab 84(2):573–577

    CAS  PubMed  Google Scholar 

  • Barrett-Connor E, Dam TT, Stone K, Harrison SL, Redline S, Orwoll E (2008) The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J Clin Endocrinol Metab 93(7):2602–2609

    PubMed Central  CAS  PubMed  Google Scholar 

  • Basaria S (2013) Reproductive aging in men. Endocrinol Metab Clin North Am 42(2):255–270

    PubMed  Google Scholar 

  • Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A, Choong K, Lakshman KM, Mazer NA, Miciek R, Krasnoff J, Elmi A, Knapp PE, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore LD, Bhasin S (2010) Adverse events associated with testosterone administration. N Engl J Med 363(2):109–122

    PubMed Central  CAS  PubMed  Google Scholar 

  • Bassil N (2011) Late-onset hypogonadism. Med Clin North Am 95(3):507–523, x

    PubMed  Google Scholar 

  • Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E (1997) Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82(8):2386–2390

    CAS  PubMed  Google Scholar 

  • Behre HM, Christin-Maitre S, Morales AM, Tostain J (2012) Transversal European survey on testosterone deficiency diagnosis. Aging Male 15(2):69–77

    PubMed  Google Scholar 

  • Bhasin S (2003) Regulation of body composition by androgens. J Endocrinol Invest 26(9):814–822

    CAS  PubMed  Google Scholar 

  • Bhasin S, Buckwalter JG (2001) Testosterone supplementation in older men: a rational idea whose time has not yet come. J Androl 22(5):718–731

    CAS  PubMed  Google Scholar 

  • Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95(6):2536–2559

    CAS  PubMed  Google Scholar 

  • Black AM, Day AG, Morales A (2004) The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial? BJU Int 94(7):1066–1070

    PubMed  Google Scholar 

  • Borst SE, Yarrow JF, Conover CF, Nseyo U, Meuleman JR, Lipinska JA, Braith RW, Beck DT, Martin JS, Morrow M, Roessner S, Beggs LA, McCoy SC, Cannady DF, Shuster JJ (2014) Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial. Am J Physiol Endocrinol Metab 306:E433–E442

    Google Scholar 

  • Breuer B, Trungold S, Martucci C, Wallenstein S, Likourezos A, Libow LS, Zumoff B (2001) Relationships of sex hormone levels to dependence in activities of daily living in the frail elderly. Maturitas 39(2):147–159

    CAS  PubMed  Google Scholar 

  • Brock GB, McVary KT, Roehrborn CG, Watts S, Ni X, Viktrup L, Wong DG, Donatucci C (2014) Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies. J Urol 191(2):405–411

    PubMed  Google Scholar 

  • Buvat J, Montorsi F, Maggi M, Porst H, Kaipia A, Colson MH, Cuzin B, Moncada I, Martin-Morales A, Yassin A, Meuleman E, Eardley I, Dean JD, Shabsigh R (2011) Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1 % hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). J Sex Med 8(1):284–293

    CAS  PubMed  Google Scholar 

  • Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S (2005) Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 60(11):1451–1457

    PubMed  Google Scholar 

  • Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M, Rosano GM (2009) Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 54(10):919–927

    CAS  PubMed  Google Scholar 

  • Carson CC 3rd, Rosano G (2012) Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data. J Sex Med 9(1):54–67

    CAS  PubMed  Google Scholar 

  • Cattabiani C, Basaria S, Ceda GP, Luci M, Vignali A, Lauretani F, Valenti G, Volpi R, Maggio M (2012) Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men. J Endocrinol Invest 35(1):104–120

    CAS  PubMed  Google Scholar 

  • Cooper LA, Page ST (2014) Androgens and prostate disease. Asian J Androl 16(2):248–255

    PubMed Central  PubMed  Google Scholar 

  • Cornil CA, Ball GF, Balthazart J (2012) Rapid control of male typical behaviors by brain-derived estrogens. Front Neuroendocrinol 33(4):425–446

    PubMed Central  CAS  PubMed  Google Scholar 

  • Corona G, Rastrelli G, Maggi M (2013a) Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best Pract Res Clin Endocrinol Metab 27(4):557–579

    CAS  PubMed  Google Scholar 

  • Corona G, Vignozzi L, Sforza A, Maggi M (2013b) Risks and benefits of late onset hypogonadism treatment: an expert opinion. World J Mens Health 31(2):103–125

    PubMed Central  PubMed  Google Scholar 

  • Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S (2008) Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab 93(3):914–919

    PubMed Central  CAS  PubMed  Google Scholar 

  • De Sousa AG, Cercato C, Mancini MC, Halpern A (2008) Obesity and obstructive sleep apnea-hypopnea syndrome. Obes Rev 9(4):340–354

    PubMed  Google Scholar 

  • Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87(2):589–598

    CAS  PubMed  Google Scholar 

  • Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos-Orozco JF, Wang AT, Erwin PJ, Bhasin S, Montori VM (2010) Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 95(6):2560–2575

    CAS  PubMed  Google Scholar 

  • Ferrando AA, Sheffield-Moore M, Paddon-Jones D, Wolfe RR, Urban RJ (2003) Differential anabolic effects of testosterone and amino acid feeding in older men. J Clin Endocrinol Metab 88(1):358–362

    CAS  PubMed  Google Scholar 

  • Fillo J, Breza J, Levcikova M, Luha J, Vachulova A, Durdik S, Labas P (2012) Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone? Int Urol Nephrol 44(4):1113–1120

    CAS  PubMed  Google Scholar 

  • Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES (2006) Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 91(10):3908–3915

    CAS  PubMed  Google Scholar 

  • Francomano D, Ilacqua A, Bruzziches R, Lenzi A, Aversa A (2014) Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome. Urology 83(1):167–174

    PubMed  Google Scholar 

  • Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R (2000) Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol 88(4):1321–1326

    CAS  PubMed  Google Scholar 

  • Garcia-Cruz E, Piqueras M, Huguet J, Perez-Marquez M, Gosalbez D, Peri L, Izquierdo L, Luque P, Ribal MJ, Alcaraz A (2012) Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy. Int J Impot Res 24(3):110–113

    CAS  PubMed  Google Scholar 

  • Garcia-Cruz E, Leibar-Tamayo A, Romero J, Piqueras M, Luque P, Cardenosa O, Alcaraz A (2013) Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. J Sex Med 10(10):2529–2538

    CAS  PubMed  Google Scholar 

  • Giltay EJ, Tishova YA, Mskhalaya GJ, Gooren LJ, Saad F, Kalinchenko SY (2010) Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. J Sex Med 7(7):2572–2582

    CAS  PubMed  Google Scholar 

  • Gooren LJ (1987) Androgen levels and sex functions in testosterone-treated hypogonadal men. Arch Sex Behav 16(6):463–473

    CAS  PubMed  Google Scholar 

  • Gray PB, Singh AB, Woodhouse LJ, Storer TW, Casaburi R, Dzekov J, Dzekov C, Sinha-Hikim I, Bhasin S (2005) Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab 90(7):3838–3846

    CAS  PubMed  Google Scholar 

  • Greco EA, Spera G, Aversa A (2006) Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. Eur Urol 50(5):940–947

    CAS  PubMed  Google Scholar 

  • Greenstein A, Mabjeesh NJ, Sofer M, Kaver I, Matzkin H, Chen J (2005) Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? J Urol 173(2):530–532

    CAS  PubMed  Google Scholar 

  • Grossmann M (2014) Testosterone and glucose metabolism in men: current concepts and controversies. J Endocrinol 220:R37–R55

    Google Scholar 

  • Grossmann M, Cheung AS, Zajac JD (2013) Androgens and prostate cancer; pathogenesis and deprivation therapy. Best Pract Res Clin Endocrinol Metab 27(4):603–616

    CAS  PubMed  Google Scholar 

  • Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P (2013) Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med 10(6):1612–1627

    CAS  PubMed  Google Scholar 

  • Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Bolona ER, Sideras K, Uraga MV, Erwin PJ, Montori VM (2007) Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 82(1):29–39

    CAS  PubMed  Google Scholar 

  • Haider A, Gooren LJ, Padungtod P, Saad F (2009) Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. Andrologia 41(1):7–13

    CAS  PubMed  Google Scholar 

  • Hajjar RR, Kaiser FE, Morley JE (1997) Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 82(11):3793–3796

    CAS  PubMed  Google Scholar 

  • Hamidi Madani A, Heidarzadeh A, Akbari Parsa N, Khosravi Darestani F, Hamidi Madani Z (2012) A survey on relative frequency of metabolic syndrome and testosterone deficiency in men with erectile dysfunction. Int Urol Nephrol 44(3):667–672

    CAS  PubMed  Google Scholar 

  • Harkonen K, Huhtaniemi I, Makinen J, Hubler D, Irjala K, Koskenvuo M, Oettel M, Raitakari O, Saad F, Pollanen P (2003) The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 26(3):187–194

    CAS  PubMed  Google Scholar 

  • Harman SM, Blackman MR (2003) The effects of growth hormone and sex steroid on lean body mass, fat mass, muscle strength, cardiovascular endurance and adverse events in healthy elderly women and men. Horm Res 60(Suppl 1):121–124

    CAS  PubMed  Google Scholar 

  • Heufelder AE, Saad F, Bunck MC, Gooren L (2009) Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl 30(6):726–733

    CAS  PubMed  Google Scholar 

  • Hildreth KL, Barry DW, Moreau KL, Vande Griend J, Meacham RB, Nakamura T, Wolfe P, Kohrt WM, Ruscin JM, Kittelson J, Cress ME, Ballard R, Schwartz RS (2013) Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels. J Clin Endocrinol Metab 98(5):1891–1900

    PubMed Central  CAS  PubMed  Google Scholar 

  • Ho CK, Beckett GJ (2011) Late-onset male hypogonadism: clinical and laboratory evaluation. J Clin Pathol 64(6):459–465

    PubMed  Google Scholar 

  • Hoekema A, Stel AL, Stegenga B, van der Hoeven JH, Wijkstra PJ, van Driel MF, de Bont LG (2007) Sexual function and obstructive sleep apnea-hypopnea: a randomized clinical trial evaluating the effects of oral-appliance and continuous positive airway pressure therapy. J Sex Med 4(4 Pt 2):1153–1162

    PubMed  Google Scholar 

  • Hoyos CM, Killick R, Yee BJ, Grunstein RR, Liu PY (2012) Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial. Clin Endocrinol (Oxf) 77(4):599–607

    CAS  Google Scholar 

  • Huhtaniemi I (2014) Late-onset hypogonadism: Current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl 16:192–202

    PubMed Central  PubMed  Google Scholar 

  • Huhtaniemi I, Forti G (2011) Male late-onset hypogonadism: pathogenesis, diagnosis and treatment. Nat Rev Urol 8(6):335–344

    CAS  PubMed  Google Scholar 

  • Ip FF, di Pierro I, Brown R, Cunningham I, Handelsman DJ, Liu PY (2010) Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets. Eur J Endocrinol 162(2):385–390

    CAS  PubMed  Google Scholar 

  • Isidori AM, Buvat J, Corona G, Goldstein I, Jannini EA, Lenzi A, Porst H, Salonia A, Traish AM, Maggi M (2014) A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol 65(1):99–112

    CAS  PubMed  Google Scholar 

  • Jain P, Rademaker AW, McVary KT (2000) Testosterone supplementation for erectile dysfunction: results of a meta-analysis. J Urol 164(2):371–375

    CAS  PubMed  Google Scholar 

  • Johnson JM, Nachtigall LB, Stern TA (2013) The effect of testosterone levels on mood in men: a review. Psychosomatics 54(6):509–514

    PubMed  Google Scholar 

  • Karazindiyanoglu S, Cayan S (2008) The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 11(3):146–149

    CAS  PubMed  Google Scholar 

  • Kelleher S, Conway AJ, Handelsman DJ (2004) Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 89(8):3813–3817

    CAS  PubMed  Google Scholar 

  • Khera M, Crawford D, Morales A, Salonia A, Morgentaler A (2014) A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 65(1):115–123

    CAS  PubMed  Google Scholar 

  • Laurent M, Antonio L, Sinnesael M, Dubois V, Gielen E, Classens F, Vanderschueren D (2014) Androgens and estrogens in skeletal sexual dimorphism. Asian J Androl 16:213–222

    Google Scholar 

  • Lin JW, Lee JK, Wu CK, Caffrey JL, Chang MH, Hwang JJ, Dowling N, Lin YS (2011) Metabolic syndrome, testosterone, and cardiovascular mortality in men. J Sex Med 8(8):2350–2360

    CAS  PubMed  Google Scholar 

  • Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, Handelsman DJ (2003) The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 88(8):3605–3613

    CAS  PubMed  Google Scholar 

  • Lopez-Jimenez F, Sert Kuniyoshi FH, Gami A, Somers VK (2008) Obstructive sleep apnea: implications for cardiac and vascular disease. Chest 133(3):793–804

    PubMed  Google Scholar 

  • Lyngdorf P, Hemmingsen L (2004) Epidemiology of erectile dysfunction and its risk factors: a practice-based study in Denmark. Int J Impot Res 16(2):105–111

    CAS  PubMed  Google Scholar 

  • Meier C, Nguyen TV, Handelsman DJ, Schindler C, Kushnir MM, Rockwood AL, Meikle AW, Center JR, Eisman JA, Seibel MJ (2008) Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 168(1):47–54

    CAS  PubMed  Google Scholar 

  • Meikle AW, Arver S, Dobs A, Sanders SW, Mazer NA (1996) Androderm: a permeation-enhanced, non-scrotal testosterone transdermal system for the treatment of male hypogonadism. In: Bhasin S (ed) Pharmacology, biology, and clinical applications of androgens. Wiley Liss, Inc, New York, pp 449–457

    Google Scholar 

  • Michael H, Harkonen PL, Vaananen HK, Hentunen TA (2005) Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 20(12):2224–2232

    CAS  PubMed  Google Scholar 

  • Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman JM, Tan HM, Torres LO (2004) Endocrine aspects of sexual dysfunction in men. J Sex Med 1(1):69–81

    CAS  PubMed  Google Scholar 

  • Morales A, Schulman CC, Tostain J, Wu FC (2006) Testosterone Deficiency Syndrome (TDS) needs to be named appropriately–the importance of accurate terminology. Eur Urol 50(3):407–409

    PubMed  Google Scholar 

  • Morgentaler A (2007) Testosterone replacement therapy and prostate cancer. Urol Clin North Am 34(4):555–563

    PubMed  Google Scholar 

  • Morgentaler A (2009) Rapidly shifting concepts regarding androgens and prostate cancer. ScientificWorldJournal 9:685–690

    CAS  PubMed  Google Scholar 

  • Morgentaler A, Schulman C (2009) Testosterone and prostate safety. Front Horm Res 37:197–203

    CAS  PubMed  Google Scholar 

  • Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D Jr, Khera M (2011) Testosterone therapy in men with untreated prostate cancer. J Urol 185(4):1256–1260

    CAS  PubMed  Google Scholar 

  • Morley JE, Perry HM 3rd, Kaiser FE, Kraenzle D, Jensen J, Houston K, Mattammal M, Perry HM Jr (1993) Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 41(2):149–152

    CAS  PubMed  Google Scholar 

  • Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FC (2004) Testosterone replacement therapy: current trends and future directions. Hum Reprod Update 10(5):409–419

    CAS  PubMed  Google Scholar 

  • O’Donnell AB, Araujo AB, McKinlay JB (2004) The health of normally aging men: the Massachusetts Male Aging Study (1987–2004). Exp Gerontol 39(7):975–984

    PubMed  Google Scholar 

  • Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90(3):1502–1510

    CAS  PubMed  Google Scholar 

  • Perry HM 3rd, Miller DK, Patrick P, Morley JE (2000) Testosterone and leptin in older African-American men: relationship to age, strength, function, and season. Metabolism 49(8):1085–1091

    CAS  PubMed  Google Scholar 

  • Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D, Hayes FJ (2005) Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28(7):1636–1642

    CAS  PubMed  Google Scholar 

  • Rao PM, Kelly DM, Jones TH (2013) Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol 9(8):479–493

    CAS  PubMed  Google Scholar 

  • Reed RL, Pearlmutter L, Yochum K, Meredith KE, Mooradian AD (1991) The relationship between muscle mass and muscle strength in the elderly. J Am Geriatr Soc 39(6):555–561

    CAS  PubMed  Google Scholar 

  • Reyes-Vallejo L, Lazarou S, Morgentaler A (2007) Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. J Sex Med 4(6):1757–1762

    CAS  PubMed  Google Scholar 

  • Rhoden EL, Morgentaler A (2004) Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350(5):482–492

    CAS  PubMed  Google Scholar 

  • Rochira V, Granata AR, Madeo B, Zirilli L, Rossi G, Carani C (2005) Estrogens in males: what have we learned in the last 10 years? Asian J Androl 7(1):3–20

    CAS  PubMed  Google Scholar 

  • Saad F, Aversa A, Isidori AM, Zafalon L, Zitzmann M, Gooren L (2011) Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 165(5):675–685

    PubMed Central  CAS  PubMed  Google Scholar 

  • Saad F, Aversa A, Isidori AM, Gooren LJ (2012) Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Curr Diabetes Rev 8:131–143

    PubMed Central  CAS  PubMed  Google Scholar 

  • Saggese G, Bertelloni S, Baroncelli GI (1997) Sex steroids and the acquisition of bone mass. Horm Res 48(Suppl 5):65–71

    CAS  PubMed  Google Scholar 

  • Schiavi RC, Rehman J (1995) Sexuality and aging. Urol Clin North Am 22(4):711–726

    CAS  PubMed  Google Scholar 

  • Schmidt PJ, Berlin KL, Danaceau MA, Neeren A, Haq NA, Roca CA, Rubinow DR (2004) The effects of pharmacologically induced hypogonadism on mood in healthy men. Arch Gen Psychiatry 61(10):997–1004

    PubMed  Google Scholar 

  • Schooling CM (2013) Androgen activity, ischaemic heart disease and risk factors among men in NHANES III. Eur J Clin Invest 43(12):1273–1281

    CAS  PubMed  Google Scholar 

  • Seidman SN, Weiser M (2013) Testosterone and mood in aging men. Psychiatr Clin North Am 36(1):177–182

    PubMed  Google Scholar 

  • Selvin E, Burnett AL, Platz EA (2007) Prevalence and risk factors for erectile dysfunction in the US. Am J Med 120(2):151–157

    PubMed  Google Scholar 

  • Shabsigh R (1997) The effects of testosterone on the cavernous tissue and erectile function. World J Urol 15(1):21–26

    CAS  PubMed  Google Scholar 

  • Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H (2004) Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172(2):658–663

    CAS  PubMed  Google Scholar 

  • Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M (2008) The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract 62(5):791–798

    PubMed Central  CAS  PubMed  Google Scholar 

  • Shelton JB, Rajfer J (2012) Androgen deficiency in aging and metabolically challenged men. Urol Clin North Am 39(1):63–75

    PubMed  Google Scholar 

  • Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C (1997) Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82(6):1661–1667

    CAS  PubMed  Google Scholar 

  • Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL (1999) Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84(6):1966–1972

    CAS  PubMed  Google Scholar 

  • Spitzer M, Huang G, Basaria S, Travison TG, Bhasin S (2013) Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol 9(7):414–424

    CAS  PubMed  Google Scholar 

  • Spivak JL (2000) The blood in systemic disorders. Lancet 355(9216):1707–1712

    CAS  PubMed  Google Scholar 

  • Srinivas-Shankar U, Roberts SA, Connolly MJ, O’Connell MD, Adams JE, Oldham JA, Wu FC (2010) Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 95(2):639–650

    CAS  PubMed  Google Scholar 

  • Svartberg J, Agledahl I, Figenschau Y, Sildnes T, Waterloo K, Jorde R (2008) Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. Int J Impot Res 20(4):378–387

    CAS  PubMed  Google Scholar 

  • Tajar A, Huhtaniemi IT, O’Neill TW, Finn JD, Pye SR, Lee DM, Bartfai G, Boonen S, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Vanderschueren D, Wu FC (2012) Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab 97(5):1508–1516

    CAS  PubMed  Google Scholar 

  • Tan WS, Ng CJ, Khoo EM, Low WY, Tan HM (2011) The triad of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome: findings from a multi-ethnic Asian men study (The Subang Men’s Health Study). Aging Male 14(4):231–236

    CAS  PubMed  Google Scholar 

  • Tracz MJ, Sideras K, Bolona ER, Haddad RM, Kennedy CC, Uraga MV, Caples SM, Erwin PJ, Montori VM (2006) Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab 91(6):2011–2016

    CAS  PubMed  Google Scholar 

  • Traish AM (2009) Androgens play a pivotal role in maintaining penile tissue architecture and erection: a review. J Androl 30(4):363–369

    CAS  PubMed  Google Scholar 

  • Traish AM, Kypreos KE (2011) Testosterone and cardiovascular disease: an old idea with modern clinical implications. Atherosclerosis 214(2):244–248

    CAS  PubMed  Google Scholar 

  • Traish AM, Saad F, Feeley RJ, Guay A (2009) The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 30(5):477–494

    CAS  PubMed  Google Scholar 

  • Traish AM, Miner MM, Morgentaler A, Zitzmann M (2011) Testosterone deficiency. Am J Med 124(7):578–587

    CAS  PubMed  Google Scholar 

  • Traish AM, Haider A, Doros G, Saad F (2013) Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract. doi:10.1111/ijcp.12319

    PubMed Central  PubMed  Google Scholar 

  • van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW (2000) Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 85(9):3276–3282

    PubMed  Google Scholar 

  • Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N (2000) Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85(8):2839–2853

    CAS  PubMed  Google Scholar 

  • Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 159(5):507–514

    PubMed Central  CAS  PubMed  Google Scholar 

  • Woodhouse LJ, Gupta N, Bhasin M, Singh AB, Ross R, Phillips J, Bhasin S (2004) Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 89(2):718–726

    CAS  PubMed  Google Scholar 

  • Yaffe K, Lui LY, Zmuda J, Cauley J (2002) Sex hormones and cognitive function in older men. J Am Geriatr Soc 50(4):707–712

    PubMed  Google Scholar 

  • Yassin AA, Saad F (2006) Dramatic improvement of penile venous leakage upon testosterone administration. A case report and review of literature. Andrologia 38(1):34–37

    CAS  PubMed  Google Scholar 

  • Yeap BB (2014) Sex steroids and cardiovascular disease. Asian J Androl 16:239–247

    Google Scholar 

  • Zitzmann M (2007) Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men. Nat Clin Pract Urol 4(3):161–166

    CAS  PubMed  Google Scholar 

  • Zitzmann M, Nieschlag E (2007) Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 92:3844–3853

    CAS  PubMed  Google Scholar 

  • Zitzmann M, Faber S, Nieschlag E (2006) Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91(11):4335–4343

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Education, Medical University of Vienna, Spitalgasse 23, Vienna, 1090, Austria

    Siegfried Meryn

Authors
  1. Siegfried Meryn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Siegfried Meryn .

Editor information

Editors and Affiliations

  1. Urology, University of Naples AOU Federico II, Naples, Italy

    Vincenzo Mirone

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Meryn, S. (2015). Testosterone Deficiency Syndrome. In: Mirone, V. (eds) Clinical Uro-Andrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45018-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45018-5_10

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45017-8

  • Online ISBN: 978-3-662-45018-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation